Prescription Pain Medication Global Market Report 2025

Description

Prescription pain medication refers to drugs that are legally prescribed by a licensed healthcare provider to manage moderate to severe pain. These medications are stronger than over-the-counter (OTC) pain relievers and are used when pain cannot be sufficiently controlled with non-prescription options.

The main types of prescription pain medications include prescription non-steroidal anti-inflammatory drugs (NSAIDs), opioids, anti-epileptic medications, antidepressants, and other types. Prescription NSAIDs are medications prescribed by healthcare professionals to reduce inflammation, relieve pain, and lower fever by inhibiting cyclooxygenase (COX) enzymes. These medications can be administered through various routes, such as oral, injectable, transdermal, and others. They are used to treat a wide range of conditions, including neuropathic pain, cancer pain, post-operative pain, and more. These drugs are distributed through various channels, including hospital pharmacies, retail pharmacies, and online pharmacies.

The prescription pain medications market research report is one of a series of new reports from The Business Research Company that provides prescription pain medications market statistics, including the prescription pain medications industry's global market size, regional shares, competitors with the prescription pain medications market share, detailed prescription pain medications market segments, market trends and opportunities, and any further data you may need to thrive in the prescription pain medications market. This prescription pain medications market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The prescription pain medication market size has grown strongly in recent years. It will grow from $73.59 billion in 2024 to $77.97 billion in 2025 at a compound annual growth rate (CAGR) of 5.9%. The growth during the historic period can be attributed to factors such as the increasing prevalence of chronic pain, a rising number of surgical procedures, a growing focus on palliative care, and an increase in musculoskeletal disorders.

The prescription pain medication market size is expected to see strong growth in the next few years. It will grow to $97.23 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%. In the forecast period, growth is expected to be driven by factors such as the increasing demand for personalized medicine, a growing focus on post-traumatic pain management, greater adoption of telemedicine for pain management, a rising number of patients seeking opioid alternatives, and an increasing prevalence of neuropathic pain. Key trends during this period include the development of non-opioid pain alternatives, the integration of digital health solutions, innovation in targeted pain therapies, the development of combination pain medications, and advancements in non-addictive pain medications.

The growing prevalence of arthritis is expected to drive the expansion of the prescription pain medication market. Arthritis, which causes inflammation in one or more joints, leads to pain, swelling, stiffness, and reduced mobility. The rising prevalence of arthritis is largely attributed to obesity, as excess weight places additional stress on joints, especially the knees, and promotes inflammation. Prescription pain medications help manage arthritis by reducing inflammation and pain, improving joint function, and enhancing the overall quality of life for those affected. For example, in March 2023, the Office for Health Improvement and Disparities, a UK-based government department, reported that in 2022, 17.6% of people aged 16 and older had arthritis or an ongoing back or joint problem, up from 17.0% in 2021. As a result, the increasing prevalence of arthritis is driving growth in the prescription pain medication market.

Companies in the prescription pain medication market are focusing on developing alternative therapies, such as non-opioid painkillers, in response to growing concerns about opioid addiction and patient safety. Non-opioid painkillers provide pain relief without the addictive risks of opioids, offering safer and more effective long-term pain management solutions while reducing the potential for addiction and overdose. For instance, in January 2025, Vertex Pharmaceuticals Incorporated, a US-based biotechnology company, received approval from the U.S. Food and Drug Administration (FDA) for JOURNAVX, a first-in-class non-opioid oral medication. This medication selectively blocks NaV1.8 sodium channels in peripheral nerves to inhibit pain signals without affecting the central nervous system, offering effective acute pain relief without the risk of addiction. It has shown clinically meaningful pain reduction in Phase 3 trials for abdominoplasty and bunionectomy with a twice-daily dosing regimen, and it is not classified as a controlled substance, addressing the need for safer acute pain management.

In October 2022, Pfizer Inc., a US-based pharmaceutical company, acquired Biohaven Pharmaceuticals for $11.6 billion. This acquisition allows Pfizer to strengthen and expand its migraine treatment portfolio, accelerate the commercialization of innovative therapies, and enhance its internal medicine pipeline for sustained growth. Biohaven Pharmaceuticals, a US-based biopharmaceutical company, manufactures prescription pain medications.

Major players in the prescription pain medication market are Mallinckrodt Public Limited Company, Pfizer Inc., Johnson And Johnson, Merck And Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis International AG, GlaxoSmithKline Public Limited Company, Takeda Pharmaceutical Company Limited, Eli Lilly And Company, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Mylan N.V., Sandoz, Inc, Bausch Health Companies Inc., Purdue Pharma L.P., Endo International Plc.

North America was the largest region in the prescription pain medication market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in prescription pain medication report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the prescription pain medication market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The prescription pain medication market consists of sales of acetaminophen, antidepressants, anticonvulsants, muscle relaxants, and biologic pain medications. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Prescription Pain Medication Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on prescription pain medication market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for prescription pain medication ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The prescription pain medication market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Prescription Non-Steroidal Anti-Inflammatory Drugs; Opioids; Anti-Epileptic Medicines; Antidepressants; Other Types
2) By Route Of Administration: Oral; Injectable; Transdermal; Other Route Of Administrations
3) By Application: Neuropathic Pain; Cancer Pain; Post-Operative Pain; Other Applications
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Subsegments:
1) By Prescription Non-Steroidal Anti-Inflammatory Drugs: COX-2 Inhibitors; Traditional Non-Steroidal Anti-Inflammatory Drugs; Combination Non-Steroidal Anti-Inflammatory Drugs
2) By Opioids: Strong Opioids; Mild Opioids; Opioid Combination Medications
3) By Anti-Epileptic Medicines: Sodium Channel Blockers; Gamma-Aminobutyric Acid Modulators; Glutamate Inhibitors
4) By Antidepressants: Selective Serotonin Reuptake Inhibitors; Tricyclic Antidepressants; Serotonin-Norepinephrine Reuptake Inhibitors; Other Antidepressants
5) By Other Types: Muscle Relaxants; Topical Pain Medications; Corticosteroids
Companies Mentioned: Mallinckrodt Public Limited Company; Pfizer Inc.; Johnson And Johnson; Merck And Co. Inc.; AbbVie Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r35576

1. Executive Summary

2. Prescription Pain Medication Market Characteristics

3. Prescription Pain Medication Market Trends And Strategies

4. Prescription Pain Medication Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Prescription Pain Medication Growth Analysis And Strategic Analysis Framework

5.1. Global Prescription Pain Medication PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Prescription Pain Medication Market Growth Rate Analysis
5.4. Global Prescription Pain Medication Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Prescription Pain Medication Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Prescription Pain Medication Total Addressable Market (TAM)

6. Prescription Pain Medication Market Segmentation

6.1. Global Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Prescription Non-Steroidal Anti-Inflammatory Drugs
Opioids
Anti-Epileptic Medicines
Antidepressants
Other Types
6.2. Global Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Injectable
Transdermal
Other Route Of Administrations
6.3. Global Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Neuropathic Pain
Cancer Pain
Post-Operative Pain
Other Applications
6.4. Global Prescription Pain Medication Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
6.5. Global Prescription Pain Medication Market, Sub-Segmentation Of Prescription Non-Steroidal Anti-Inflammatory Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
COX-2 Inhibitors
Traditional Non-Steroidal Anti-Inflammatory Drugs
Combination Non-Steroidal Anti-Inflammatory Drugs
6.6. Global Prescription Pain Medication Market, Sub-Segmentation Of Opioids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Strong Opioids
Mild Opioids
Opioid Combination Medications
6.7. Global Prescription Pain Medication Market, Sub-Segmentation Of Anti-Epileptic Medicines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Sodium Channel Blockers
Gamma-Aminobutyric Acid Modulators
Glutamate Inhibitors
6.8. Global Prescription Pain Medication Market, Sub-Segmentation Of Antidepressants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Selective Serotonin Reuptake Inhibitors
Tricyclic Antidepressants
Serotonin-Norepinephrine Reuptake Inhibitors
Other Antidepressants
6.9. Global Prescription Pain Medication Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Muscle Relaxants
Topical Pain Medications
Corticosteroids

7. Prescription Pain Medication Market Regional And Country Analysis

7.1. Global Prescription Pain Medication Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Prescription Pain Medication Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Prescription Pain Medication Market

8.1. Asia-Pacific Prescription Pain Medication Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Prescription Pain Medication Market

9.1. China Prescription Pain Medication Market Overview
9.2. China Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Prescription Pain Medication Market

10.1. India Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Prescription Pain Medication Market

11.1. Japan Prescription Pain Medication Market Overview
11.2. Japan Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Prescription Pain Medication Market

12.1. Australia Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Prescription Pain Medication Market

13.1. Indonesia Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Prescription Pain Medication Market

14.1. South Korea Prescription Pain Medication Market Overview
14.2. South Korea Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Prescription Pain Medication Market

15.1. Western Europe Prescription Pain Medication Market Overview
15.2. Western Europe Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Prescription Pain Medication Market

16.1. UK Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Prescription Pain Medication Market

17.1. Germany Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Prescription Pain Medication Market

18.1. France Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Prescription Pain Medication Market

19.1. Italy Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Prescription Pain Medication Market

20.1. Spain Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Prescription Pain Medication Market

21.1. Eastern Europe Prescription Pain Medication Market Overview
21.2. Eastern Europe Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Prescription Pain Medication Market

22.1. Russia Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Prescription Pain Medication Market

23.1. North America Prescription Pain Medication Market Overview
23.2. North America Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Prescription Pain Medication Market

24.1. USA Prescription Pain Medication Market Overview
24.2. USA Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Prescription Pain Medication Market

25.1. Canada Prescription Pain Medication Market Overview
25.2. Canada Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Prescription Pain Medication Market

26.1. South America Prescription Pain Medication Market Overview
26.2. South America Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Prescription Pain Medication Market

27.1. Brazil Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Prescription Pain Medication Market

28.1. Middle East Prescription Pain Medication Market Overview
28.2. Middle East Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Prescription Pain Medication Market

29.1. Africa Prescription Pain Medication Market Overview
29.2. Africa Prescription Pain Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Prescription Pain Medication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Prescription Pain Medication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Prescription Pain Medication Market Competitive Landscape And Company Profiles

30.1. Prescription Pain Medication Market Competitive Landscape
30.2. Prescription Pain Medication Market Company Profiles
- 30.2.1. Mallinckrodt Public Limited Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Johnson And Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Merck And Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Prescription Pain Medication Market Other Major And Innovative Companies

31.1. Bayer AG
31.2. Sanofi S.A.
31.3. Bristol-Myers Squibb Company
31.4. AstraZeneca plc
31.5. Novartis International AG
31.6. GlaxoSmithKline Public Limited Company
31.7. Takeda Pharmaceutical Company Limited
31.8. Eli Lilly And Company
31.9. Teva Pharmaceutical Industries Ltd.
31.10. Boehringer Ingelheim GmbH
31.11. Mylan N.V.
31.12. Sandoz, Inc
31.13. Bausch Health Companies Inc.
31.14. Purdue Pharma L.P.
31.15. Endo International Plc

32. Global Prescription Pain Medication Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Prescription Pain Medication Market

34. Recent Developments In The Prescription Pain Medication Market

35. Prescription Pain Medication Market High Potential Countries, Segments and Strategies

35.1 Prescription Pain Medication Market In 2029 - Countries Offering Most New Opportunities
35.2 Prescription Pain Medication Market In 2029 - Segments Offering Most New Opportunities
35.3 Prescription Pain Medication Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer